inflammatory drug. Upon oral ad min istration it undergoes first pass metabolism and because of its short biological half-life, the drug has to be administered frequently. The physicochemical, pharmacokinetic and pharmacological properties of this drug make it well suited for transdermal drug development as the biological half life of the DFS is less than 4hrs (1.2to2hrs),mo lecular weight is less than 400 Dalton (296 Dalton), dose of drug is less 20mg/day for transdermal ad ministration. The DFS is neither highly lipophilic, nor highly hydrophilic and it is suitable for transdermal delivery but shows low permeability and hence not easily absorbed on transdermal applicat ion 1, 2 .
To overcome the less permeability of drugs through the skin, fewer strategies have been used. Most of them use penetration enhancer which is a popular technique. These agents partition into, and interact with, the stratum corneum constituents to induce a temporary, reversible increase in skin permeability. Usually, terpenes enhance drug permeat ion by any of the following three mechanis ms: disruption of the highly ordered lipid structure of stratum corneum; increased drug diffusivity in stratum corneum or increased drug partitioning into stratum corneum 3 .
Therefore many compounds, such as terpenes (geraniol and menthol), isopropyl myristate, nicotinic acid esters, hydrogenated soya phospholipid, ethanol, n-octanol and decanol and nonionic surfactants have been reported to enhance the permeation of DFS through the skin [4] [5] [6] [7] [8] [9] . Out of them terpenes are widely used as penetration enhancers 10 .
The calendula oil is a volatile oil d istilled fro m flowers of Calendula officinalis (Asteraceae). After systematic studies, the various constituents of this oil found were α-cadinene, α-cadinol, t-muurolo l, menthol, 1,8-cineol, terpene-4-ol,geraniol with p-cy mene 11,1 2 .
The enhancing effect of calendula oil on the in vitro percutaneous absorption of diclofenac sodium (DFS) fro m carbopol gels containing propylene glycol was investigated in artificial skin memb rane considering the fact that the calendula oil a lso contains different terpenes which have been identified by GC-M S analysis 12 . The permeat ion effect of calendula oil on DFS is compared with geraniol and menthol (mild accelerants).
MATERIALS AND METHOD:

Materials:
Diclofenac sodium (a g ift sample o f Zim laboratory Pvt. Ltd. India), carbopol (Loba chemicals), propylene glycol and triethanolamine (Fine chemical), geraniol and menthol (BASF,Mu mbai), calendula o il (ext racted fro m calendula flowers by using Clevenger apparatus) and artificial skin memb rane (Dialysis membrane 70 Code-DM003: LA 393-1MT HIM EDIA).
Drug formulati ons:
The gel were prepared by adding 1% drugs in the formulat ion shown in Table 1 .
Characterizati on of gel: pH: ABS TRACT:
Terpenes are widely used as p enetration enhancers in transdermal drug delivery systems. Calendula oil also contains different terpenes. The enhancing effect of calendula oil on the in-vitro percutaneous absorption of diclofenac sodium (DFS) from carbopol gels containing propylene glycol was investigated. Permeation experiments were performed on artificial skin membrane. The permeation effect of calendula oil on DFS was compared with geraniol and menthol (mild accelerants). The enhancing effect of calendula oil was found to be more as compared with geraniol and menthol. However, although the addition of calendula oil increased DFS flux; diffusional lag times were longer than for the control gel. The pH of various gel formu lations was determined by using digital pH meter. One gram of gel was dissolved in 100 ml distilled water and stored for 30 minutes. The measurement of pH of each formu lation was done in triplicate and average values were calcu lated. 
Triethanolami ne 3.50 3.50 3.50 3.50
Water (ad 100 g m)
Drug content:
1 g of the prepared gel was mixed with 100ml phosphate buffer. A liquots of different concentration were prepared by suitable dilutions after filtering the stock solution and absorbance was recorded using UV spectrophotometer at 276 n m. Drug content was calculated using the equation, which was obtained by linear regression analysis of calibrat ion curve.
Viscosity:
The measurement of viscosity of the prepared gel was done with a Brookfield Visco meter. The gels were rotated at 100 rotations per minute and the corresponding dial reading was noted. The viscosity of the gel was obtained by mult iplication of the dial reading with factor given in the Brookefield Viscometer catalogues.
Spreadability:
One of the criteria for a gel to meet the ideal quantities is that it should possess good spreadability. It is the term expressed to denote the extent of area to which gel readily spreads on application to skin or affected part. The therapeutic efficacy of a formu lation also depends upon its spreading value.
Spreadability (S) is exp ressed in terms of time in seconds taken by two slides to slip off fro m gel and placed in between the slides under the direction of certain load. Lesser the time taken for separation of two slides, better the spreadability. It is calcu lated by using the formula:
Where M = wt. tied to upper slide L = length of glass slides T = t ime taken to separate the slides
Extrudability study:
The formulat ions were filled into collapsible metal tubes after the gels were set in the container. The extrudability of formulat ion was determined. It is a usual empirical test to measure the force required to extrude the material fro m tube. In the present study, the method adopted for evaluating gel formulation for ext rudability was based upon the quantity of gel and gel extruded from lacquered alu minu m co llapsible tube on application of weight in grams required to extrude at least 0.5 cm ribbon of gel in 10 seconds. More quantity extruded better was extrudability. The values of gel formulat ions obtained are shown in Table 2 . 
In-vitro permeati on study:
The artificial skin membrane was equilibrated in isotonic phosphate buffer (pH 7.4) for 2 h before being mounted on a Franz-type diffusion cell with an available diffusion area of 1.76 cm 2 .The receptor phase consisted of a phosphate buffer solution (pH 7.4, 25 ml), stirred at 600 rp m with the help of magnetic bead and maintained at 37°C. The synthetic semi-permeable membrane was mounted between the donor and receptor compart ments. The gel (1 g) formu lation was applied to the memb rane. Samp les were withdrawn through sample port of the Franz diffusion cell at predetermined time interval over 24 hours and analyzed by UV spectrophotometer at 276 nm. The receptor phase was immediately replenished with equal volume of phosphate buffer solution of pH 7.4.
The permeat ion profiles of DFS through artificial skin memb rane fro m plain carbopol gels (F1), containing calendula oil (F4) and different terpene (F2, F3) as penetration enhancers are given in Fig. 1 . The flu x, J, was determined fro m the slopes at steady-state and the lag time fro m the x-intercept. The permeability coefficient, Kp, was estimated fro m the flu x and the donor drug concentration. The effects of calendula oil and terpene enhancers on DFS permeat ion parameters are summarized in Table 3 . Penetration-enhancing activities are expressed as enhancement ratios(ER) which is the ratio of the Kp value with enhancer to that obtained with plain carbopol gel. The flu x values of different gel formu lations are shown in 
RES ULTS AND DISCUSS ION:
These results demonstrate that the calendula oil is an effective accelerant for DFS drug as compared to geraniol and menthol. The most outstanding penetration enhancer was calendula oil, providing an almost 20-fo ld increase in DFS permeab ility coefficient, fo llo wed by geraniol, and then menthol. Eventhough penetration enhancing effects of geraniol are closely related with calendula oil, the skin care properties of calendula oil may be an added advantage and it can be used in various transdermal co mmercial formu lations as an effective penetration enhancer.
